HOME >> BIOLOGY >> NEWS
AAAS CEO Alan I. Leshner welcomes proposed Washington state legislation on stem cell research

WASHINGTON, D.C.-AAAS has welcomed efforts by Washington state legislators to pass a bill banning reproductive cloning in the state while allowing research on human embryonic stem cells.

In letters sent to two sponsors of the bill, Alan I. Leshner, the chief executive officer of AAAS and executive publisher of the journal Science, reaffirmed the association's position that cloning to extract stem cells from early-stage human embryos for research purposes "holds great promise." But he also noted that "the benefits will only be realized through carefully designed research" that is subject to appropriate ethical and legal oversight. And he reiterated that AAAS has endorsed a legal ban on any efforts to clone human embryos to produce babies.

Leshner's letter was faxed Monday 28 March 28 2005 as a committee of the Washington State Senate holds a hearing on the bill, which already has been approved by the state's House of Representatives. The letter was sent to state Rep. Shay Schual-Berke, a physician and sponsor of the bill in the House, and state Sen. Jeanne Kohl-Welles, a co-sponsor in the Senate who has a Ph.D. in sociology. Both are Democrats.

The bill includes some specific ethical guidelines, such as the patient's right to full disclosure and civil penalties for reproductive cloning.

Legislators in several states, including Maryland, have attempted to follow the lead of California in backing stem cell research that President George W. Bush restricted at the federal level in 2001. In Congress, the House leadership reportedly has agreed to allow a floor vote this session on a proposal to ease the federal restrictions and allow study of newer stem cell lines derived from embryos discarded by fertility clinics.

[For more information, read the full letter. ]


'"/>


29-Mar-2005


Page: 1

Related biology news :

1. Statement from Dr. Alan I. Leshner, CEO of AAAS, on the Kansas State Board of Education vote
2. AAAS CEO Alan I. Leshner urges US to continue collecting job data on women workers
3. AAAS CEO Alan I. Leshner registers strong concerns over suppression of science films
4. AAAS CEO Alan I. Leshner statement on the UN cloning debate
5. National Inventors Hall of Fame welcomes 2005 inductees
6. BioMed Central welcomes the new National Institutes of Health public access policy
7. Telemedicine initiative for sub-Saharan Africa: Pilot projects proposed
8. Major initiative proposed to address amphibian crisis
9. AIDS research agenda proposed
10. New model of p53 regulation proposed that suggests novel anticancer strategy
11. Mechanism proposed for link between RU-486 and fatal infections

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/22/2017)... VILNIUS, Lithuania , March 21, 2017 /PRNewswire/ ... identification and object recognition technologies, today announced the ... development kit (SDK), which provides improved facial recognition ... safety cameras on a single computer. The new ... algorithms to improve accuracy, and it utilizes a ...
(Date:3/20/2017)... Germany , March 20, 2017 At this ... Hamburg -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG ... is this year,s CeBIT partner country. At the largest German ... biometrics in use: fingerprint, face and iris recognition as well as DERMALOG´s ... ...
(Date:3/13/2017)... Germany , March 13, 2017 Future of security: ... ... DERMALOGs Face Matching enables to match face ... forms the basis to identify individuals. (PRNewsFoto/Dermalog Identification Systems) ... DERMALOG,s "Face Matching" is the fastest software for biometric ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... , March 23, 2017  SeraCare ... to global in vitro diagnostics manufacturers and ... the industry,s first multiplexed Inherited Cancer ... testing by next-generation sequencing (NGS). The Seraseq™ ... developed with input from industry experts to ...
(Date:3/23/2017)... March 23, 2017  BioPharmX Corporation (NYSE MKT: ... the dermatology market, today reported financial results for ... and will provide an update on the company,s ... "We are pleased to report that ... BioPharmX," said President Anja Krammer. "We achieved key ...
(Date:3/23/2017)... , March 23, 2017 Kineta, Inc., ... of novel therapies in immuno-oncology, today announced the ... small molecule compounds that activate interferon response factor ... and demonstrate immune-mediated tumor regression in a murine ... study who demonstrated complete tumor regression to initial ...
(Date:3/23/2017)... ALBANY, New York , March 23, 2017 ... animal blood plasma products and derivatives market is fragmented due to the ... large players, such as Proliant, Thermo Fisher , and Sigma-Aldrich, ... clear leader, these three companies, collectively, held more than 76% of ... ...
Breaking Biology Technology:
Cached News: